The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 88,200 |
| Depreciation and amortization | 104,200 |
| Impairment charges | 6,500 |
| Unrealized foreign exchange (gain) loss | 4,300 |
| Stock-based compensation | 58,200 |
| Lease amortization | 86,500 |
| Loss on debt extinguishment | -3,000 |
| Amortization of debt issuance costs | 8,000 |
| Earnings from equity method investments, net of distributions received | -3,000 |
| Impairment of equity method investment | 177,000 |
| Change in deferred taxes | 45,000 |
| Provision for loss on receivables and other assets | 22,200 |
| Loss on disposition of business | 0 |
| Unrealized (gain) loss on investments, net | 26,100 |
| Other operating activities, net | 30,300 |
| Trade and other receivables | 139,900 |
| Income taxes payable | 10,900 |
| Short-term contract assets and prepaid expenses and other current assets | -30,200 |
| Other non-current assets | 121,200 |
| Accounts payable and accrued expenses | 108,700 |
| Accrued compensation | 106,700 |
| Other current and non-current liabilities | -106,100 |
| Net cash provided by operating activities | 340,400 |
| Payment for property and equipment | 47,400 |
| Acquisition of business, net of cash acquired | 4,900 |
| Investments in equity securities | 8,900 |
| Return of beneficial interest in a securitization | 630,000 |
| Collection on beneficial interest in a securitization | 650,000 |
| Proceeds from disposition of business or other investments | 11,500 |
| Other investing activities, net | -8,600 |
| Net cash (used in) provided by investing activities | -21,100 |
| Shares repurchased for payment of employee taxes on stock awards | 11,200 |
| Payment of deferred and contingent consideration | 13,000 |
| Proceeds from borrowings | 0 |
| Repayment of borrowings | 300,000 |
| Debt issuance costs | 0 |
| Payment of finance lease liabilities | 26,100 |
| Other financing activities, net | -200 |
| Net cash used in financing activities | -350,500 |
| Change in cash, cash equivalents and restricted cash | -31,200 |
| Cash, cash equivalents and restricted cash, beginning of the year | 814,600 |
| Effects of exchange rate fluctuations on cash, cash equivalents and restricted cash | 20,100 |
| Cash, cash equivalents and restricted cash, end of the year | 803,500 |
Cushman & Wakefield Ltd. (CWK)
Cushman & Wakefield Ltd. (CWK)